Search:

Product Information All Elsevier Sites   Advanced Product Search
SiteStat.jsp
DRUG DISCOVERY
Drug Discovery
From Bedside to Wall Street
To order this title, and for more information, click here

By
Tamas Bartfai, Harold L. Dorris Neurological Research Center and Scripps Research Institute, La Jolla, California, USA
Graham Lees, Publishing Director, TheScientificWorld Ltd., Newbury, U.K.

Description
Everyone expects something from the drug industry. Physicians and patients, investors, regulators and administrators all have an active interest. Everyone wants to know what makes drugs ?work? medically and economically. Why are drugs so expensive? Is it the drug companies or investors who demand high profits? What governs the pharmacoeconomics? Why are so few diseases treatable? This book opens the windows and doors of the industry telling the story of drug development by using real stories from inside the process.

Audience
Academics/Scientists interested in working with biotech and pharma companies

Contents
Proposed Contents: 1. The Art of Putting a Molecule Into Man 2. Raising & Rising Expectations 3. History is good to know 4. The "Better Betablocker Barrier" 5. Why Some Good Drugs Do Not Get a Chance & Why 6. About the Economics of Target and Clinical Candidate Selection 7. Target Based Drug Discovery: Part I 8. Changes Need to be Made 9. Target Based Drug Discovery, Part II 10. "Drugable" Targets 11. So Many Drugs, So Few Entities 12. How to Find a Candidate 13. Practicalities: The Hoops & Hurdles of Big Pharma 14. Practical Trials for a Balanced Portfolio 15. How to Improve the Odds of Finding a Safe Drug that Works 16. The Tribulations of Clinical Trials 17. Linking Putative Targets to Disease States 18. More Ways to Look for Targets 19. The Business Basics 20. Adding Value in a Growth of Industry 21. What's the Most Profitable Approach? 22. Pharmacoeconomics for Biotech 23. Shrinking Value of Targets 24. Assessing Company Assets? Look in the Library 25. To Merge or Not to Merge? 26. Working with the Food & Drug Administration (FDA) 27. Regulating Regulatory Regimens Reliably 28. The Hypothesis Is: There is a Better Way 29. What are "We" all Working on? 30. More Tablets Taken per Day than Meals Served

Bibliographic details
Paperback, 328 pages, publication date: DEC-2005
ISBN-13: 978-0-12-369533-8
ISBN-10: 0-12-369533-3
Imprint: ACADEMIC PRESS

Price and Ordering
Price:
GBP 18.20
EUR 20.27
USD 39.95
order now
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.

999/999
Last update: 5 Sep 2009
Book contents
Table of contents
Reviews
View other people's reviews
Submit your review
Bookmark this page
Recommend this publication
Overview of all books
Printer-friendly version   Printer-friendly version